drugset / Trial / NCT00474279

Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional Ability of Older Adults

NCT00474279 ↗

Phase 1/2 Completed 72 enrolled University of Virginia
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine whether treatment of healthy older men and women with oral MK-677 for 12 months will enhance pulsatile GH release and increase mean GH and IGF-I concentrations into the range of young adults and will have favorable effects on body composition and functional ability on older adults.

Timeline

Start
1998-07
Primary completion
—
Completion
2004-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibutamoren Small molecule — Oral

Indications

No indication recorded.